Implantable Microdevice In Primary Brain Tumors

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 3, 2020

Primary Completion Date

January 21, 2028

Study Completion Date

June 1, 2028

Conditions
Grade II GliomaGrade III GliomaGrade IV GliomaAstrocytomaOligodendroglioma of BrainAnaplastic Astrocytoma of BrainAnaplastic OligodendrogliomaGlioblastoma
Interventions
COMBINATION_PRODUCT

Microdevice

"Placement of 1-3 microdevices (depending on the size of the tumor) before tumor resection is started.~The microdevices will dwell in the tumor tissue for a time window of 2-4 hours to allow time for tissue effects of the drugs (Temozolomide, Lomustine, Irinotecan, Carboplatin, Lapatinib, Osimertinib, Abenaciclib, and Everolimus) released by the microdevice reservoirs. The drugs used in this study will only include drugs already used systemically for the treatment of gliomas."

Trial Locations (1)

02115

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Oliver Jonas

OTHER